Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03PYD
|
||||
Former ID |
DNCL001740
|
||||
Drug Name |
K-604
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arteriosclerosis [ICD9: 440; ICD10:I70] | Phase 2 | [522595] | ||
Company |
Kowa Pharmaceuticals America
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H26N2O2
|
||||
Canonical SMILES |
CC1CC(C2=CC=CC=C2N1C(=O)C3=CC=CC=C3)N(C4=CC=CC=C4)C(=O)<br />C5CC5
|
||||
InChI |
1S/C27H26N2O2/c1-19-18-25(29(27(31)21-16-17-21)22-12-6-3-7-13-22)23-14-8-9-15-24(23)28(19)26(30)20-10-4-2-5-11-20/h2-15,19,21,25H,16-18H2,1H3
|
||||
InChIKey |
VGFZCFWVSYIXEK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [528287] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.